The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Metagenomic Sequencing-Global Market Insights and Sales Trends 2024
Synopsis
Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investigated at a much greater scale and detail than before.
The global Metagenomic Sequencing market size is expected to reach US$ 1745.6 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Metagenomic Sequencing in various end use industries. The expanding demands from the Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization and Drug Discovery, are propelling Metagenomic Sequencing market. Shotgun Metagenomic Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 16S rRNA Sequencing segment is estimated at % CAGR for the next seven-year period.
The data generated by metagenomics experiments are both enormous and inherently noisy, containing fragmented data representing as many as 10,000 species. The sequencing of the cow rumen metagenome generated 279 giga bases, or 279 billion base pairs of nucleotide sequence data, while the human gut microbiome gene catalog identified 3.3 million genes assembled from 567.7 gigabases of sequence data. Collecting, curating, and extracting useful biological information from datasets of this size represent significant computational challenges for researchers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metagenomic Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metagenomic Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metagenomic Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metagenomic Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metagenomic Sequencing covered in this report include GATC Biotech, Enterome Bioscience, Illumina, Quest Diagnostics, Roche, Thermo Fisher Scientific, CLC Bio, Agilent Technologies and Macrogen, etc.
The global Metagenomic Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GATC Biotech
Enterome Bioscience
Illumina
Quest Diagnostics
Roche
Thermo Fisher Scientific
CLC Bio
Agilent Technologies
Macrogen
Helicos BioSciences
QIAGEN
Global Metagenomic Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metagenomic Sequencing market, Segment by Type:
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-genome Sequencing & De Novo Assembly
Global Metagenomic Sequencing market, by Application
Clinical Diagnostic
Environmental Remediation
Gut Microbe Characterization
Drug Discovery
Biofuel
Agriculture
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metagenomic Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investigated at a much greater scale and detail than before.
The global Metagenomic Sequencing market size is expected to reach US$ 1745.6 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Metagenomic Sequencing in various end use industries. The expanding demands from the Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization and Drug Discovery, are propelling Metagenomic Sequencing market. Shotgun Metagenomic Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 16S rRNA Sequencing segment is estimated at % CAGR for the next seven-year period.
The data generated by metagenomics experiments are both enormous and inherently noisy, containing fragmented data representing as many as 10,000 species. The sequencing of the cow rumen metagenome generated 279 giga bases, or 279 billion base pairs of nucleotide sequence data, while the human gut microbiome gene catalog identified 3.3 million genes assembled from 567.7 gigabases of sequence data. Collecting, curating, and extracting useful biological information from datasets of this size represent significant computational challenges for researchers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metagenomic Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metagenomic Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metagenomic Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metagenomic Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metagenomic Sequencing covered in this report include GATC Biotech, Enterome Bioscience, Illumina, Quest Diagnostics, Roche, Thermo Fisher Scientific, CLC Bio, Agilent Technologies and Macrogen, etc.
The global Metagenomic Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GATC Biotech
Enterome Bioscience
Illumina
Quest Diagnostics
Roche
Thermo Fisher Scientific
CLC Bio
Agilent Technologies
Macrogen
Helicos BioSciences
QIAGEN
Global Metagenomic Sequencing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metagenomic Sequencing market, Segment by Type:
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-genome Sequencing & De Novo Assembly
Global Metagenomic Sequencing market, by Application
Clinical Diagnostic
Environmental Remediation
Gut Microbe Characterization
Drug Discovery
Biofuel
Agriculture
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metagenomic Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Metagenomic Sequencing
1.1 Metagenomic Sequencing Market Overview
1.1.1 Metagenomic Sequencing Product Scope
1.1.2 Metagenomic Sequencing Market Status and Outlook
1.2 Global Metagenomic Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metagenomic Sequencing Market Size by Region (2018-2029)
1.4 Global Metagenomic Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Metagenomic Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metagenomic Sequencing Market Size (2018-2029)
1.6.1 North America Metagenomic Sequencing Market Size (2018-2029)
1.6.2 Europe Metagenomic Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Metagenomic Sequencing Market Size (2018-2029)
1.6.4 Latin America Metagenomic Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Metagenomic Sequencing Market Size (2018-2029)
2 Metagenomic Sequencing Market by Type
2.1 Introduction
2.1.1 Shotgun Metagenomic Sequencing
2.1.2 16S rRNA Sequencing
2.1.3 Metatranscriptomics
2.1.4 Whole-genome Sequencing & De Novo Assembly
2.2 Global Metagenomic Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Metagenomic Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Metagenomic Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Metagenomic Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Metagenomic Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Metagenomic Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Metagenomic Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Metagenomic Sequencing Revenue Breakdown by Type (2018-2029)
3 Metagenomic Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Clinical Diagnostic
3.1.2 Environmental Remediation
3.1.3 Gut Microbe Characterization
3.1.4 Drug Discovery
3.1.5 Biofuel
3.1.6 Agriculture
3.1.7 Others
3.2 Global Metagenomic Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metagenomic Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Metagenomic Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metagenomic Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metagenomic Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metagenomic Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metagenomic Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metagenomic Sequencing Revenue Breakdown by Application (2018-2029)
4 Metagenomic Sequencing Competition Analysis by Players
4.1 Global Metagenomic Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metagenomic Sequencing as of 2022)
4.3 Date of Key Players Enter into Metagenomic Sequencing Market
4.4 Global Top Players Metagenomic Sequencing Headquarters and Area Served
4.5 Key Players Metagenomic Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Metagenomic Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GATC Biotech
5.1.1 GATC Biotech Profile
5.1.2 GATC Biotech Main Business
5.1.3 GATC Biotech Metagenomic Sequencing Products, Services and Solutions
5.1.4 GATC Biotech Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 GATC Biotech Recent Developments
5.2 Enterome Bioscience
5.2.1 Enterome Bioscience Profile
5.2.2 Enterome Bioscience Main Business
5.2.3 Enterome Bioscience Metagenomic Sequencing Products, Services and Solutions
5.2.4 Enterome Bioscience Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 Enterome Bioscience Recent Developments
5.3 Illumina
5.3.1 Illumina Profile
5.3.2 Illumina Main Business
5.3.3 Illumina Metagenomic Sequencing Products, Services and Solutions
5.3.4 Illumina Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Metagenomic Sequencing Products, Services and Solutions
5.4.4 Quest Diagnostics Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Metagenomic Sequencing Products, Services and Solutions
5.5.4 Roche Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Metagenomic Sequencing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 CLC Bio
5.7.1 CLC Bio Profile
5.7.2 CLC Bio Main Business
5.7.3 CLC Bio Metagenomic Sequencing Products, Services and Solutions
5.7.4 CLC Bio Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 CLC Bio Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Metagenomic Sequencing Products, Services and Solutions
5.8.4 Agilent Technologies Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 Agilent Technologies Recent Developments
5.9 Macrogen
5.9.1 Macrogen Profile
5.9.2 Macrogen Main Business
5.9.3 Macrogen Metagenomic Sequencing Products, Services and Solutions
5.9.4 Macrogen Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 Macrogen Recent Developments
5.10 Helicos BioSciences
5.10.1 Helicos BioSciences Profile
5.10.2 Helicos BioSciences Main Business
5.10.3 Helicos BioSciences Metagenomic Sequencing Products, Services and Solutions
5.10.4 Helicos BioSciences Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.10.5 Helicos BioSciences Recent Developments
5.11 QIAGEN
5.11.1 QIAGEN Profile
5.11.2 QIAGEN Main Business
5.11.3 QIAGEN Metagenomic Sequencing Products, Services and Solutions
5.11.4 QIAGEN Metagenomic Sequencing Revenue (US$ Million) & (2018-2023)
5.11.5 QIAGEN Recent Developments
6 North America
6.1 North America Metagenomic Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metagenomic Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metagenomic Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metagenomic Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metagenomic Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metagenomic Sequencing Market Dynamics
11.1 Metagenomic Sequencing Industry Trends
11.2 Metagenomic Sequencing Market Drivers
11.3 Metagenomic Sequencing Market Challenges
11.4 Metagenomic Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
